NCT05544006 (AIDMy-HF) is a clinical trial in Heart Failure, sponsored by Albert Saglik Hizmetleri ve Ticaret A.S..

Who is sponsoring NCT05544006?

NCT05544006 is sponsored by Albert Saglik Hizmetleri ve Ticaret A.S..

What condition does NCT05544006 study?

NCT05544006 studies Heart Failure.

Is NCT05544006 still recruiting?

NCT05544006 is currently status unknown. Last updated 1 December 2022.

Last reviewed 2022-12-01 · How we verify

NCT05544006: AIDMy-HF

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Artificial Intelligence-Based Disease Management in the Vulnerable Period of Heart Failure

Status unknown Last updated 1 December 2022

What this trial tests

trial in Heart Failure in 76 participants. Status unknown.

Timeline

26 October 2022

Primary endpoint
30 March 2023

2 April 2023

Quick facts

Lead sponsor	Albert Saglik Hizmetleri ve Ticaret A.S.
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	76
Start date	26 October 2022
Primary completion	30 March 2023
Estimated completion	2 April 2023
Sites	1 location across Turkey (Türkiye)

Conditions studied

Heart Failure — all drugs for Heart Failure →

Sponsor

Albert Saglik Hizmetleri ve Ticaret A.S.

Who can join

Adults 18 to 85, any sex, with Heart Failure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study aims to evaluate the effect of AI-based discharge training after acute decompensation of heart failure on the patient's quality of life and to examine the relationship between changes in voice and speech characteristics of patients and changes in hospitalization, discharge, and early post-discharge clinical status.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Heart Failure

Currently open trials in the same condition.

NCT06118983 — Improving TRansitions ANd OutcomeS for Heart FailurE Patients in Home Health CaRe (I-TRANSFER-HF) · NA · recruiting
NCT07496372 — Efficacy and Safety of Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Injection (HiCM-188) in Advanced Heart · Phase 3 · recruiting
NCT07527156 — Prolonged Nasogastric Administration of Ketones in Decompensated Heart Failure · Phase 4 · recruiting
NCT07263035 — Urine Sodium-Driven Diuretic Adjustment Strategy in Acute Decompensated Heart Failure · Phase 4 · recruiting
NCT07531966 — Vascular Complications After Kidney Transplantation · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05544006 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Albert Saglik Hizmetleri ve Ticaret A.S.
Last refreshed: 1 December 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05544006.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing